Continuing Education Courses
Continuing Education for MLS & MLT
Continuing Education for Phlebotomists
Continuing Education for Histologists
HR Courses
Intro to the Medical Lab
Video Continuing Education Courses
All Available Courses
Exam Simulators
Exam Simulator for MLS & MLT
NSH + LabCE Histology Exam Simulator
Phlebotomy Exam Simulator
Molecular Exam Simulator
Case Simulators
RBC Morphology Simulator
White Blood Cell Differential Case Simulator
Advanced WBC Differential Case Simulator
Urinalysis Case Simulator
Body Fluid Case Simulator
Bacteriology Case Simulator
Blood Culture Gram Stain Case Simulator
LabCE Quiz Game
Contact & Support
Log In
Log In
Moving forward, what is not considered an important strategy for dealing with MRSA strains?
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 178 CE courses, most popular
$109
Add to cart
Pick Your Courses
Up to 8 CE hours
$55
Add to cart
Individual course
$25
Add to cart
Need multiple seats for your university or lab?
Get a quote
The page below is a sample from the LabCE course
Drug-Resistant Superbugs, Multi-drug Resistant Organisms: MRSA, VRE, Clostridioides difficile, and CRE
. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.
Learn more about Drug-Resistant Superbugs, Multi-drug Resistant Organisms: MRSA, VRE, Clostridioides difficile, and CRE (online CE course)
Moving forward, what is
not
considered an important strategy for dealing with MRSA strains?
Please select the single best answer
Antimicrobial stewardship to guide the use of both existing alternatives and newer drugs.
Identification of MRSA strains in all settings (inpatient as well as outpatient).
Increase in vancomycin treatment of MRSA to eliminate infections more efficiently.
Possible development of vaccines.
X
×